Froome fails doping test

Above, British cyclist Chris Froome celebrates on the podium after winning the 72nd edition of Spain’s Vuelta e Espana race in September. (AFP)
Updated 13 December 2017
0

Froome fails doping test

PARIS: Chris Froome failed a doping test during the Spanish Vuelta in September and is facing suspension from the sport ahead of his attempt to win a record-equaling fifth Tour de France title next year.
Froome won his fourth Tour title this year and followed it with a victory at the Vuelta. But Team Sky said yesterday that Froome, who has not been suspended, had a concentration of asthma drug salbutamol two times higher than the World Anti-Doping Agency’s permitted levels.
“Analysis indicated the presence of salbutamol at a concentration of 2,000 nanograms per milliliter (ng/ml), compared with the WADA threshold of 1,000 ng/ml,” Team Sky said.
Team Sky said it has been informed by the International Cycling Union that the urine test was taken on Sept. 7, during the three-week Spanish Vuelta.
Froome said the UCI has asked him to provide information about the failed test, which was taken after Stage 18.
Froome’s use of asthma medication has been well documented, and the Kenyan-born rider has often been spotted using inhalers in the peloton. He has repeatedly faced questions on whether he is a clean rider, especially during the Tour de France, and has always denied wrongdoing.
Salbutamol is a drug that helps expand lung capacity and can be used as a performance-enhancing drug to increase endurance. Commonly marketed as Ventolin, salbutamol is classified as a beta-2 agonist and WADA allows it to be taken through inhalation only, in limited amounts.
Sky said Froome had to take an increased dosage of salbutamol without exceeding the permissible dose after he “experienced acute asthma symptoms” during the final week of the Vuelta.
If found guilty of doping, the 32-year-old Froome could lose his Vuelta title and be suspended for a long period. Sprinter Alessandro Petacchi was suspended for one year for testing positive for salbutamol during the 2007 Giro d’Italia.
Vuelta organizers said they will not comment until they receive official notification about the case.
Froome was expected to attempt to join cycling greats Eddy Merckx, Bernard Hinault and Miguel Indurain on the list of five-time Tour de France champions in July. Lance Armstrong won seven titles, but all of them were stripped because of doping.
Team Sky has been dominating the field at the Tour de France in recent years, but has been targeted by doping accusations. Britain’s anti-doping agency last month closed an investigation into the team without bringing charges. The case centered on the contents of a medical package dispatched to former Tour champion Bradley Wiggins at a key pre-Tour race in 2011.
Team Sky was established in 2009 by Dave Brailsford, the man behind Britain’s 14 medals at the 2008 Beijing Olympics, with the target of producing the country’s first Tour champion — a feat accomplished by Wiggins in 2012. Froome, his former teammate, has taken over since as Britain’s most successful road rider.
After successfully defending his Tour de France title in July, Froome went on to win the Spanish Vuelta for the first time.
“My asthma got worse at the Vuelta so I followed the team doctor’s advice to increase my salbutamol dosage,” Froome said. “As always, I took the greatest care to ensure that I did not use more than the permissible dose. I take my leadership position in my sport very seriously. The UCI is absolutely right to examine test results and, together with the team, I will provide whatever information it requires.”
The UCI said in a statement that Froome’s “B” sample confirmed the result, but stressed that “the presence of a specified substance such as salbutamol in a sample does not result in the imposition of such mandatory provisional suspension against the rider.”
Sky said the abnormal result does not mean Froome has breached anti-doping rules and Brailsford insisted he has the “utmost confidence that Chris followed the medical guidance in managing his asthma symptoms, staying within the permissible dose for salbutamol.”
Froome said last month that he wants to ride in next year’s Giro d’Italia in an attempt to win his third Grand Tour in a row. A victory at the Italian race would make him the seventh rider to win all three Grand Tours, and only the third to hold the three titles at the same time.


Sixth season of ​​Formula E to start in Saudi Arabia’s Ad Diriyah in November

Updated 16 June 2019
0

Sixth season of ​​Formula E to start in Saudi Arabia’s Ad Diriyah in November

  • The electric cars competition will witness two rounds as part of the sixth ABB FIA Formula E event
  • Fourteen such events are scheduled in 12 cities on four different continents

RIYADH: FIA World Motor Sport Council revealed on Saturday that the 2019 Saudia Ad Diriyah E Prix will kick off the new season on Nov. 22 and 23, 2019, on the outskirts of Riyadh.

The electric cars competition, organized by the FIA and the Saudi Arabia General Sport Authority (GSA), will witness two rounds as part of the sixth ABB FIA Formula E competition, out of 14 organized in 12 cities on four different continents including, Santiago, Mexico City, Hong Kong, Rome, Paris, Berlin, New York, and London and Seoul, which were recently added.

Alberto Longo, vice CEO of Formula E, said that the upcoming season will be one of the most exciting in the short history of the competition.

He also welcomed Mercedes Benz and Porsche to the list of competitors, and Seoul and London to the competition’s venues.

He said that the present season is about to end with three more rounds to go, and that there is a fierce competition for the title.

CHAMPIONSHIP PROGRAM

● Nov. 22: Ad Diriyah, Saudi Arabia

● Nov. 23: Ad Diriyah, Saudi Arabia

● Dec. 14: TBA

● Jan. 18, 2020: Santiago, Chile

● Feb. 15, 2020: Mexico City, Mexico

● March 1, 2020: Hong Kong, China

● March 21, 2020: TBA — China

● April 4, 2020: Rome, Italy

● 9 April 18, 2020: Paris, France

● 10 May 3, 2020: Seoul, S. Korea

● 11 May 30, 2020: Berlin, Germany

● 12 June 20, 2020: New York, US

● 13 July 25, 2020: London, UK

● 14 July 26, 2020: London, UK